Literature DB >> 25147637

Recurrent neurocysticercosis.

Asad Jehangir1, Esther Hwang2, Anam Qureshi3, Qasim Jehangir4.   

Abstract

Entities:  

Year:  2014        PMID: 25147637      PMCID: PMC4120056          DOI: 10.3402/jchimp.v4.24586

Source DB:  PubMed          Journal:  J Community Hosp Intern Med Perspect        ISSN: 2000-9666


× No keyword cloud information.
Neurocysticercosis is fairly common, with up to 5,000 new cases in the USA every year (1). New onset neurological symptoms in patients with a history of neurocysticercosis should make the physician suspect recurrent neurocysticercosis as a potential etiology, as a considerable number of patients suffer from late neurologic sequelae (2). Radiological imaging helps in the diagnosis. CT has a better sensitivity to detect calcifications, but MRI is the most accurate imaging modality. Four recognized stages on MRI are vesicular, colloid vesicular, granular nodular, and nodular calcified. Cystic lesions demonstrating the scolex as a bright nodule, known as the ‘hole-with-dot’, is pathognomonic (3). FLAIR images have the maximum rate of scolex detection, whereas the last gadolinium-enhanced T1-weighted series identifies the maximum number of lesions, which can influence the management plan (3). Treatment depends on the location and number of lesions, which usually involves antiepileptic therapy and a short course of steroids with a rapid taper.

Case presentation

A 52-year-old Hispanic male with a history of seizures secondary to neurocysticercosis diagnosed and treated about 10 years ago came to ED with complaints of difficulty speaking and right-sided weakness. His home medications included topiramate. On examination, he had aphasia and partial complex seizure–like activity involving the right extremities. A CT scan of the head showed scattered parenchymal calcifications, including a 7 mm calcified area in left parietal, compatible with prior history of neurocysticercosis. MRI of the brain revealed a 1 cm ring enhancing calcified lesion with surrounding edema within the left parietal lobe with the appearance compatible with an active cysticercosis lesion. There were other areas of calcification within the brain without edematous change or enhancement, likely secondary to healed areas of cysticercosis. The patient was treated with a 2-week course of albendazole 400 mg BID and Decadron 4 mg BID and was advised to follow-up with neurology to taper steroids. In addition to topiramate, he was also prescribed levetiracetam to prevent further seizures. CT Head: Multiple calcifications from neurocysticercosis, largest calcification of 7 mm in left parietal lobe. MRI Brain AX T1 + C1 Flair: 1 cm ring enhancing calcified lesion within the left parietal lobe with the appearance compatible with an active cysticercosis lesion.
  3 in total

1.  The role of conventional MR imaging sequences in the evaluation of neurocysticercosis: impact on characterization of the scolex and lesion burden.

Authors:  L T Lucato; M S Guedes; J R Sato; L A Bacheschi; L R Machado; C C Leite
Journal:  AJNR Am J Neuroradiol       Date:  2007-09       Impact factor: 3.825

2.  Neurocysticercosis in the United States.

Authors:  Jose A Serpa; A Clinton White
Journal:  Pathog Glob Health       Date:  2012-09       Impact factor: 2.894

3.  Outcomes of medical treatment of neurocysticercosis: a study of 65 cases in Cheju Island, Korea.

Authors:  S K Kim; K C Wang; S H Paek; K S Hong; B K Cho
Journal:  Surg Neurol       Date:  1999-12
  3 in total
  1 in total

1.  Editor's Note.

Authors:  Robert P Ferguson
Journal:  J Community Hosp Intern Med Perspect       Date:  2014-07-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.